There is much to do.
The healthcare sector is responsible for about 6% of Denmark's total climate footprint. In regional climate accounts, medicines account for around 20% of the regions climate footprint. Medicine residues in wastewater from production and consumption of medicinal products contain substances that are harmful to humans and animals. Waste volumes from Danish hospitals are enormous; plastic waste alone amounts to 4,000 tonnes annually.
“These are figures we cannot turn our backs to. Especially because Amgros is responsible for supplying public hospitals with almost all the medicines they use. There are also the ambitious climate targets set by both the UN and changing Danish governments. Consequently, we are faced with major challenges and tasks, and we must take responsibility. We will and must contribute,” says Flemming Sonne, CEO of Amgros.
As a central player in the healthcare system, we at Amgros aim to use our influence to reduce the negative environmental and climate impacts of medicines and promote responsible business conduct in all links in the supply chain, from raw materials, to manufacture and distribution, to the treatment of patients.
Following good and close dialogue with our stakeholders, more specifically we have decided to focus on four areas: the climate, responsible business conduct, the circular economy as well as medicine residues in waste water and anti-microbial resistance. We have chosen the climate as our highest priority, because we all have only a few years to curb temperature rises and global warming.